A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • Publications
  • Devex: How AI can push for equitable access t...
Published on 19 Nov 2020
Share
Publication

Devex: How AI can push for equitable access to COVID-19 vaccines

Writing for Devex, Access to Medicine Foundation Executive Director Jayasree K. Iyer and Researcher Thomas Collin-Lefebvre explore the issue of artificial intelligence and its potential role in facilitating access to medicines and vaccines in low- and middle-income countries (LMICs).

Explore further

Media

BBC talks to Jayasree K. Iyer about pharma company social responsibility and access to medicine

Jayasree K. Iyer talks about pharmaceutical companies’ approaches to access to medicine, licensing and equitable pricing to ensure that their products are available and accessible to people in low- and middle-income countries.

Media

Promoting Equitable Access to COVID Relief with Mara Lilley

The Access to Medicine Foundation's Investor Engagement Manager, Mara Lilley, joins The Gadfly podcast to discuss equitable access to prospective COVID-19 treatments.
Key finding: COVID-19

R&D for COVID-19 has increased, yet other pandemic risks go unaddressed

Despite years of warnings that novel coronaviruses were among the pathogens most likely to cause a global health emergency, the pharmaceutical industry, as well as society at large, was ill-prepared for the COVID-19 pandemic.

Get in touch

Back to top |